U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ACRIXOLIMAB
INN  
Official Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-441) (VH (HOMO SAPIENS IGHV3-30*01 (95.8%)-(IGHD)- IGHJ5*01 (100%), CDR-IMGT (8.8.7) (26-
Common Name English
acrixolimab [INN]
Common Name English
IMMUNOGLOBULIN G4 (222-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN MONOCLONAL YBL-006 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL YBL-006 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
CAS
2506324-29-2
Created by admin on Sat Dec 16 18:17:38 GMT 2023 , Edited by admin on Sat Dec 16 18:17:38 GMT 2023
PRIMARY
FDA UNII
KHG83J8RMW
Created by admin on Sat Dec 16 18:17:38 GMT 2023 , Edited by admin on Sat Dec 16 18:17:38 GMT 2023
PRIMARY
INN
11969
Created by admin on Sat Dec 16 18:17:38 GMT 2023 , Edited by admin on Sat Dec 16 18:17:38 GMT 2023
PRIMARY
NCI_THESAURUS
C188591
Created by admin on Sat Dec 16 18:17:38 GMT 2023 , Edited by admin on Sat Dec 16 18:17:38 GMT 2023
PRIMARY
SUBSTANCE RECORD
ACRIXOLIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966